625 related articles for article (PubMed ID: 30019172)
1. Clinical Pharmacokinetics and Pharmacodynamics of Propofol.
Sahinovic MM; Struys MMRF; Absalom AR
Clin Pharmacokinet; 2018 Dec; 57(12):1539-1558. PubMed ID: 30019172
[TBL] [Abstract][Full Text] [Related]
2. Prospective clinical validation of the Eleveld propofol pharmacokinetic-pharmacodynamic model in general anaesthesia.
Vellinga R; Hannivoort LN; Introna M; Touw DJ; Absalom AR; Eleveld DJ; Struys MMRF
Br J Anaesth; 2021 Feb; 126(2):386-394. PubMed ID: 33317804
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetic-pharmacodynamic modeling and dosing simulation of propofol maintenance anesthesia in severely obese adolescents.
Chidambaran V; Venkatasubramanian R; Sadhasivam S; Esslinger H; Cox S; Diepstraten J; Fukuda T; Inge T; Knibbe CAJ; Vinks AA
Paediatr Anaesth; 2015 Sep; 25(9):911-923. PubMed ID: 25975390
[TBL] [Abstract][Full Text] [Related]
4. Refining Target-Controlled Infusion: An Assessment of Pharmacodynamic Target-Controlled Infusion of Propofol and Remifentanil Using a Response Surface Model of Their Combined Effects on Bispectral Index.
Short TG; Hannam JA; Laurent S; Campbell D; Misur M; Merry AF; Tam YH
Anesth Analg; 2016 Jan; 122(1):90-7. PubMed ID: 26683103
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of propofol and fentanyl in patients undergoing abdominal aortic surgery - a study of pharmacodynamic drug-drug interactions.
Wiczling P; Bieda K; Przybyłowski K; Hartmann-Sobczyńska R; Borsuk A; Matysiak J; Kokot ZJ; Sobczyński P; Grześkowiak E; Bienert A
Biopharm Drug Dispos; 2016 Jul; 37(5):252-63. PubMed ID: 26990035
[TBL] [Abstract][Full Text] [Related]
6. Induction speed is not a determinant of propofol pharmacodynamics.
Doufas AG; Bakhshandeh M; Bjorksten AR; Shafer SL; Sessler DI
Anesthesiology; 2004 Nov; 101(5):1112-21. PubMed ID: 15505446
[TBL] [Abstract][Full Text] [Related]
7. Propofol: a review of its role in pediatric anesthesia and sedation.
Chidambaran V; Costandi A; D'Mello A
CNS Drugs; 2015 Jul; 29(7):543-63. PubMed ID: 26290263
[TBL] [Abstract][Full Text] [Related]
8. Performance of propofol target-controlled infusion models in the obese: pharmacokinetic and pharmacodynamic analysis.
Cortínez LI; De la Fuente N; Eleveld DJ; Oliveros A; Crovari F; Sepulveda P; Ibacache M; Solari S
Anesth Analg; 2014 Aug; 119(2):302-310. PubMed ID: 24977639
[TBL] [Abstract][Full Text] [Related]
9. Clinical interpretation of pharmacokinetic and pharmacodynamic propofol-opioid interactions.
Vuyk J
Acta Anaesthesiol Belg; 2001; 52(4):445-51. PubMed ID: 11799580
[TBL] [Abstract][Full Text] [Related]
10. Early phase pharmacokinetics but not pharmacodynamics are influenced by propofol infusion rate.
Masui K; Kira M; Kazama T; Hagihira S; Mortier EP; Struys MM
Anesthesiology; 2009 Oct; 111(4):805-17. PubMed ID: 19741485
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic-pharmacodynamic model for propofol for broad application in anaesthesia and sedation.
Eleveld DJ; Colin P; Absalom AR; Struys MMRF
Br J Anaesth; 2018 May; 120(5):942-959. PubMed ID: 29661412
[TBL] [Abstract][Full Text] [Related]
12. Propofol: a sedative-hypnotic anesthetic agent for use in ambulatory procedures.
Steinbacher DM
Anesth Prog; 2001; 48(2):66-71. PubMed ID: 11515950
[No Abstract] [Full Text] [Related]
13. Effect-Site Target-Controlled Infusion in the Obese: Model Derivation and Performance Assessment.
Cortínez LI; Sepúlveda P; Rolle A; Cottin P; Guerrini A; Anderson BJ
Anesth Analg; 2018 Oct; 127(4):865-872. PubMed ID: 29401079
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.
Knibbe CA; Zuideveld KP; DeJongh J; Kuks PF; Aarts LP; Danhof M
Clin Pharmacol Ther; 2002 Dec; 72(6):670-84. PubMed ID: 12496748
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic and pharmacodynamic model of propofol externally validated in Korean elderly subjects.
Kim KM; Choi BM; Noh GJ
J Pharmacokinet Pharmacodyn; 2023 Apr; 50(2):97-109. PubMed ID: 36522561
[TBL] [Abstract][Full Text] [Related]
16. Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients.
Calvo R; Telletxea S; Leal N; Aguilera L; Suarez E; De La Fuente L; Martin-Suarez A; Lukas JC
Acta Anaesthesiol Scand; 2004 Sep; 48(8):1038-48. PubMed ID: 15315624
[TBL] [Abstract][Full Text] [Related]
17. Mixed-effects modeling of the influence of midazolam on propofol pharmacokinetics.
Vuyk J; Lichtenbelt BJ; Olofsen E; van Kleef JW; Dahan A
Anesth Analg; 2009 May; 108(5):1522-30. PubMed ID: 19372331
[TBL] [Abstract][Full Text] [Related]
18. The role of pharmacokinetics and pharmacodynamics in clinical anaesthesia practice.
Hannivoort LN; Absalom AR; Struys MMRF
Curr Opin Anaesthesiol; 2020 Aug; 33(4):483-489. PubMed ID: 32530894
[TBL] [Abstract][Full Text] [Related]
19. Morbid Obesity Alters Both Pharmacokinetics and Pharmacodynamics of Propofol: Dosing Recommendation for Anesthesia Induction.
Dong D; Peng X; Liu J; Qian H; Li J; Wu B
Drug Metab Dispos; 2016 Oct; 44(10):1579-83. PubMed ID: 27481855
[TBL] [Abstract][Full Text] [Related]
20. The performance of compartmental and physiologically based recirculatory pharmacokinetic models for propofol: a comparison using bolus, continuous, and target-controlled infusion data.
Masui K; Upton RN; Doufas AG; Coetzee JF; Kazama T; Mortier EP; Struys MM
Anesth Analg; 2010 Aug; 111(2):368-79. PubMed ID: 19861357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
